We are finally at the end of the work week and this is what I am reading in the home stretch:
- Hot to not: The valuation implosion at Theranos
- A Biotech Executive Faces End-Stage Cancer As A Patient – Definitely worth watching the embedded video included with the story.
- For smaller companies, a presence at BIO conference is a big deal
- A CRISPR Pioneer on Gene Editing: ‘We Shouldn’t Screw It Up’
Have a great weekend!